Sun Pharma Acquires US-Based Organon in $11.75 Billion Deal
Sun Pharmaceutical Industries, India's largest pharmaceutical company, announced a definitive agreement to acquire Organon & Co. — a US-based women's health and biosimilars company — in an all-cash deal valued at $11.75 billion. Under the agreement, Sun Pharma will purchase all outstanding shares of Organon at $14.00 per share. This ranks among the largest-ever outbound acquisitions by an Indian company and significantly expands Sun Pharma's presence in the US and global biosimilars market.
Key Facts & Details
7 points- 1Sun Pharma to acquire US-based Organon for $11.75 billion (all-cash)
- 2Deal price: $14.00 per share for all outstanding Organon shares
- 3One of the largest outbound acquisitions by an Indian company
Deep Dive
- +Organon specializes in women's health, biosimilars, and established brands
- +Sun Pharma is headquartered in Mumbai and is India's largest pharma company by revenue
- +The deal strengthens Sun Pharma's global footprint, especially in the US market
- +India's pharmaceutical industry is the world's third-largest by volume and a key exporter of generic medicines
Exam Focus
Likely MCQ: Sun Pharma acquired which US company for $11.75 billion in April 2026? → Answer: Organon & Co.
Related Topics
Exam Relevance & Angle
Important for Banking GK & Business Awareness: Major Indian corporate acquisitions and pharma sector developments.
Target Exams
Background & Context
Sun Pharmaceutical Industries Ltd was founded by Dilip Shanghvi in 1983 and is headquartered in Mumbai, Maharashtra. It is India's largest pharmaceutical company and among the world's top generic drug makers. Sun Pharma previously acquired Ranbaxy Laboratories in 2014 in a $4 billion deal.
Organon & Co. was spun off from Merck & Co. in 2021 as an independent company focused on women's health products, biosimilars, and established pharmaceutical brands. It is headquartered in Jersey City, New Jersey, USA.
India's pharmaceutical industry is valued at over $50 billion and supplies about 20% of global generic medicine demand. It is often called the 'Pharmacy of the World'.
Related GK Concepts
Must KnowTest Yourself
1 / 3Sun Pharma's $11.75 billion acquisition of Organon is an example of what type of corporate deal?
This topic is important for:
